MENU
+Compare
IBBQ
ETF ticker: NASDAQ
AS OF
Jun 3 closing price
Price
$20.89
Change
+$0.16 (+0.77%)
Net Assets
36.25M

IBBQ stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®... Show more

Category: #Health
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IBBQ with price predictions
Jun 02, 2025

Aroon Indicator for IBBQ shows an upward move is likely

IBBQ's Aroon Indicator triggered a bullish signal on May 13, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 148 similar instances where the Aroon Indicator showed a similar pattern. In of the 148 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on IBBQ as a result. In of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IBBQ just turned positive on May 19, 2025. Looking at past instances where IBBQ's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

IBBQ moved above its 50-day moving average on June 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IBBQ crossed bullishly above the 50-day moving average on May 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBBQ advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where IBBQ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBBQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Nasdaq Biotechnology ETF ETF is 5.2B. The market cap for tickers in the group ranges from 23.42M to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is QTTB at 23.42M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 1%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was -8%. BMEA experienced the highest price growth at 75%, while ALMS experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 65%. For the same stocks of the ETF, the average monthly volume growth was 25% and the average quarterly volume growth was 56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 100
Price Growth Rating: 67
SMR Rating: 100
Profit Risk Rating: 88
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
PowerShares Exchange-Traded Fund Tr II301 West Roosevelt RoadWheaton
Phone
N/A
Web
www.invescopowershares.com